EW
Edwards Lifesciences Corp
NYSE · Healthcare · Medical - Devices · US
$87.22
+0.72%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$86.66
From 52W high−8.36%
Volume2.76M
Market cap$50.27B
P/E (TTM)50.1x
P/S (TTM)7.7x
Div yield—
Key dataOct 19, 2026
Open
$86.66
From 52W high
−8.36%
Volume
2.76M
Market cap
$50.27B
ValuationView details →
P/E (Fwd)
26.8x
EV/EBITDA
29.6x
P/E (TTM)
50.1x
RSI (14)
50.3
MomentumView details →
1D Return
+0.72%
YTD Return
+1.98%
SummaryUpdated Jun 1, 2026
Edwards Lifesciences Corporation (NYSE:EW) is a leading medical device company founded in 1958 and headquartered in Irvine, California. The company has evolved from its origins as a division of American Hospital Supply Corporation to become a specialized leader in structural heart disease and critical care monitoring technologies. Edwards went public in 2000 and has since focused increasingly on structural heart therapies, completing the sale of its Critical Care business in 2024 to concentrate solely on treating heart valve diseases and related conditions.
Similar companies
Latest newsMore news →
The European Commission selected products from Edwards Lifesciences Corp and HighLife SAS as the first medical devices to undergo joint clinical assessment.11d agoEdwards Lifesciences Corp plans to announce its operating results for the quarter ended September 30, 2026, after market close on November 4, 2026, and host a conference call that day at 5:00 p.m. ET.12d ago